Bo Shen
Senior Director, CMC Drug Substance | Expert in Process R&D | Delivering Phase-Appropriate Drug Substance Strategies
- Role
- Senior Director, Cmc Drug Substance at Prelude Therapeutics
- Location
- Wilmington, DE, US
- LinkedIn followers
- 500 followers
About Bo Shen
Small molecule drug substance development professional with extensive experience in scalable API process development and CMC strategy execution. Proven track record in building phase-appropriate manufacturing strategies, overseeing global CRO/CDMO partnerships, and supporting regulatory submissions.
Experience
Senior Director, Cmc Drug Substance
Mar 2026 — Present
Education
Indiana University Bloomington
transferred to Vanderbilt University
Vanderbilt University
PhD, Organic Chemistry
2006 — 2010
University of Science and Technology of China
BS, Chemistry
Skills
- Catalysis
- Ir
- Chromatography
- Purification
- Hplc
- Organic Chemistry
- Drug Discovery
- Organic Synthesis
- Nmr Spectroscopy
- Lc-Ms
- Nmr
- Mass Spectrometry
- Medicinal Chemistry
- Science
- Chemistry
- Uv-Vis
- Uv/Vis
- Synthetic Organic Chemistry
- Characterization
- Spectroscopy
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.